Steve O'Loughlin
2021
In 2021, Steve O'Loughlin earned a total compensation of $967K as Chief Financial Officer at Actinium Pharmaceuticals, a 18% increase compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $447,034 |
| Salary | $370,000 |
| Total | $967,034 |
O'Loughlin received $447K in option awards, accounting for 46% of the total pay in 2021.
O'Loughlin also received $150K in bonus and $370K in salary.
Rankings
In 2021, Steve O'Loughlin's compensation ranked 8,885th out of 12,415 executives tracked by ExecPay. In other words, O'Loughlin earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,885 out of 12,415 | 28th |
Division Manufacturing | 3,935 out of 5,508 | 29th |
Major group Chemicals And Allied Products | 1,732 out of 2,378 | 27th |
Industry group Drugs | 1,541 out of 2,099 | 27th |
Industry Pharmaceutical Preparations | 1,148 out of 1,549 | 26th |
Source: SEC filing on November 21, 2022.
O'Loughlin's colleagues
We found three more compensation records of executives who worked with Steve O'Loughlin at Actinium Pharmaceuticals in 2021.
News
Actinium Pharmaceuticals CEO Sandesh Seth's 2023 pay rises 17% to $4.7M
November 5, 2024
Actinium Pharmaceuticals CEO Sandesh Seth's 2022 pay jumps 72% to $4M
November 9, 2023
Actinium Pharmaceuticals CEO Sandesh Seth's 2021 pay jumps 27% to $2.3M
November 21, 2022
Actinium Pharmaceuticals CEO Sandesh Seth's 2019 pay slips 20% to $1.1M
October 7, 2020